Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Recurrent Malignant Thymoma clinical trials

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Recurrent Malignant Thymoma: 1 US clinical trial tracked, none currently recruiting.

Recurrent Malignant Thymoma is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is M.D. Anderson Cancer Center, running 1 of these trials.

Enrollment posture brief

Registry condition recurrent-malignant-thymoma

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Recurrent Malignant Thym (th…0%
Open-enrollment share among volume-matched conditions near Recurrent Malignant Thymoma

Recurrent Malignant Thymoma has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Recurrent Malignant Thymoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Recurrent Malignant Thymoma is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Recurrent Malignant Thymoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Diaphragm Fluoroscopy Procedure
1 trials
Magnetic Resonance Imaging Procedure
1 trials

US sites by state

Facility locations filed on Recurrent Malignant Thymoma trials. A trial with sites in several states counts in each.

Texas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Recurrent Malignant Thymoma page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Recurrent Malignant Thymoma trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • M.D. Anderson Cancer Center sponsors the most Recurrent Malignant Thymoma trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Recurrent Malignant Thymoma condition card totals 1 registered trials; most-linked intervention Diaphragm Fluoroscopy; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.